Boston Scientific Corp (BSX): Revenue
$20.07B
Year ended 2025-12-31
$21.00B
Trailing 12 months to 2026-06-30
+16.5%
3-year compound annual growth
+15.2%
5-year compound annual growth
+10.4%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $20.07B | +19.9% | 2026-02-17, From 2025-01-01 |
| 2024-12-31 | $16.75B | +17.6% | 2026-02-17, From 2024-01-01 |
| 2023-12-31 | $14.24B | +12.3% | 2026-02-17, From 2023-01-01 |
| 2022-12-31 | $12.68B | +6.7% | 2025-02-18, From 2022-01-01 |
| 2021-12-31 | $11.89B | +19.9% | 2024-02-20, From 2021-01-01 |
| 2020-12-31 | $9.91B | -7.7% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $10.73B | +9.3% | 2022-02-23, From 2019-01-01 |
| 2018-12-31 | $9.82B | +8.6% | 2021-02-23, From 2018-01-01 |
| 2017-12-31 | $9.05B | +7.9% | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | $8.39B | +12.2% | 2019-02-19, From 2016-01-01 |
| 2015-12-31 | $7.48B | +1.3% | 2018-02-20, From 2015-01-01 |
| 2014-12-31 | $7.38B | +3.3% | 2017-02-23, From 2014-01-01 |
| 2013-12-31 | $7.14B | -1.5% | 2016-02-24, From 2013-01-01 |
| 2012-12-31 | $7.25B | -4.9% | 2015-02-25, From 2012-01-01 |
| 2011-12-31 | $7.62B | -2.4% | 2014-02-26, From 2011-01-01 |
| 2010-12-31 | $7.81B | -4.7% | 2013-02-22, From 2010-01-01 |
| 2009-12-31 | $8.19B | +1.7% | 2012-02-17, From 2009-01-01 |
| 2008-12-31 | $8.05B | -3.7% | 2011-02-17, From 2008-01-01 |
| 2007-12-31 | $8.36B | n/a | 2010-02-26, From 2007-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Boston Scientific Corp (BSX) | 2025-12-31 | $20.07B | +19.9% |
| Becton Dickinson & Co (BDX) | 2025-09-30 | $21.84B | +8.2% |
| 3M Co (MMM) | 2025-12-31 | $24.95B | +1.5% |
| Stryker Corp (SYK) | 2025-12-31 | $25.12B | +11.2% |
| Medline Inc. (MDLN) | 2025-12-31 | $28.43B | +11.5% |
| Baxter International Inc (BAX) | 2025-12-31 | $11.24B | +5.7% |
| Solventum Corp (SOLV) | 2025-12-31 | $8.32B | +0.9% |
| ResMed Inc (RMD) | 2026-06-30 | $5.65B | +9.9% |
| Dexcom Inc (DXCM) | 2025-12-31 | $4.66B | +15.6% |
Compare BSX, BDX, MMM, SYK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗